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Résumé en
anglais
This study assessed the prognostic value of several markers involved in
gliomagenesis, and compared it with that of other clinical and imaging markers
already used. Four-hundred and sixteen adult patients with newly diagnosed glioma
were included over a 3-year period and tumour suppressor genes, oncogenes, MGMT
and hTERT expressions, losses of heterozygosity, as well as relevant clinical and
imaging information were recorded. This prospective study was based on all adult
gliomas. Analyses were performed on patient groups selected according to World
Health Organization histoprognostic criteria and on the entire cohort. The endpoint
was overall survival, estimated by the Kaplan-Meier method. Univariate analysis was
followed by multivariate analysis according to a Cox model. p14(ARF), p16(INK4A)
and PTEN expressions, and 10p 10q23, 10q26 and 13q LOH for the entire cohort,
hTERT expression for high-grade tumours, EGFR for glioblastomas, 10q26 LOH for
grade III tumours and anaplastic oligodendrogliomas were found to be correlated
with overall survival on univariate analysis and age and grade on multivariate
analysis only. This study confirms the prognostic value of several markers. However,
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